HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. [PDF]
Xie Y +14 more
europepmc +1 more source
Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B. [PDF]
Zhao W +9 more
europepmc +1 more source
Hepatitis B Virus e Antigen in Mother-to-Child Transmission and Clinical Management of Hepatitis B. [PDF]
Ning Q, Ou JJ.
europepmc +1 more source
A meta-analysis of controlled clinical trials comparing peginterferon-α plus nucleos(t)ide analogs versus peginterferon-α monotherapy for HBsAg clearance or seroconversion in patients with chronic hepatitis B. [PDF]
Zhu S, Yang Z, Wang Y, Cai X, Qin C.
europepmc +1 more source
No Immediate Need for Nucleos(t)ide Analogs Treatment in Untreated Patients With Low-Level Viremia: Evidence From Hepatitis B Virus RNA Levels. [PDF]
Zhang Y +5 more
europepmc +1 more source
"When the virus ages with the patient": Disease-specific quality of life in individuals with hepatitis B virus infection in Ghana. [PDF]
Oblie FNO +5 more
europepmc +1 more source
[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]
Wang ZW +11 more
europepmc +1 more source
Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China. [PDF]
Hou J +23 more
europepmc +1 more source

